(Q39128545)

English

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.

scientific article published on October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Simian immunodeficiency virus

0 references

Stephen J. Kent

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

David C. Montefiori

7

object named as

David C Montefiori

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

12

object named as

Matthew Law

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

C Jane Dale

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Charani Ranasinghe

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Ivan Stratov

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Socheata Chea

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Scott Thomson

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Ian A Ramshaw

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Barbara E H Coupar

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

David B Boyle

11

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Kim M Wilson

13

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Alistair J Ramsay

14

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

5009-5021

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Vaginal CD4+ T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Target cells in vaginal HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.05.032

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39128545&oldid=1449255262"